Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With HIV
- PMID: 38366369
- PMCID: PMC11175700
- DOI: 10.1093/infdis/jiae016
Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With HIV
Abstract
Background: The relationship between accelerated epigenetic aging and musculoskeletal outcomes in women with HIV (WWH) has not been studied.
Methods: We measured DNA methylation age using the Infinium MethylationEPIC BeadChip in a cohort from the Women's Interagency HIV Study (n = 190) with measures of bone mineral density (BMD) and physical function. We estimated 6 biomarkers of epigenetic aging-epigenetic age acceleration (EAA), extrinsic EAA, intrinsic EAA, GrimAge, PhenoAge, and DNA methylation-estimated telomere length-and evaluated associations of epigenetic aging measures with BMD and physical function. We also performed epigenome-wide association studies to examine associations of DNA methylation signatures with BMD and physical function.
Results: This study included 118 WWH (mean age, 49.7 years; 69% Black) and 72 without HIV (mean age, 48.9 years; 69% Black). WWH had higher EAA (mean ± SD, 1.44 ± 5.36 vs -1.88 ± 5.07; P < .001) and lower DNA methylation-estimated telomere length (7.13 ± 0.31 vs 7.34 ± 0.23, P < .001) than women without HIV. There were no significant associations between accelerated epigenetic aging and BMD. Rather, measures of accelerated epigenetic aging were associated with lower physical function.
Conclusions: Accelerated epigenetic aging was observed in WWH as compared with women without HIV and was associated with lower physical function in both groups.
Keywords: HIV; bone mineral density; epigenetic aging; osteoporosis; physical function.
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts.
Figures

Similar articles
-
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.Lancet HIV. 2021 Apr;8(4):e197-e205. doi: 10.1016/S2352-3018(21)00006-0. Lancet HIV. 2021. PMID: 33794182
-
Epigenetic Aging Biomarkers Associated With Cognitive Impairment in Older African American Adults With Human Immunodeficiency Virus (HIV).Clin Infect Dis. 2021 Dec 6;73(11):1982-1991. doi: 10.1093/cid/ciab563. Clin Infect Dis. 2021. PMID: 34143869 Free PMC article.
-
Genome-wide association studies identify novel genetic loci for epigenetic age acceleration among survivors of childhood cancer.Genome Med. 2022 Mar 22;14(1):32. doi: 10.1186/s13073-022-01038-6. Genome Med. 2022. PMID: 35313970 Free PMC article.
-
Epigenetic regulation of bone mass.Best Pract Res Clin Endocrinol Metab. 2022 Mar;36(2):101612. doi: 10.1016/j.beem.2021.101612. Epub 2022 Jan 4. Best Pract Res Clin Endocrinol Metab. 2022. PMID: 35120798 Free PMC article. Review.
-
Anti-Aging Tests for Middle Aged Women.J Menopausal Med. 2024 Dec;30(3):164-169. doi: 10.6118/jmm.24012. J Menopausal Med. 2024. PMID: 39829193 Free PMC article. Review.
Cited by
-
Perspective: clinical relevance of epigenetic aging and HIV.Epigenomics. 2025 Jun;17(8):523-527. doi: 10.1080/17501911.2025.2491299. Epub 2025 Apr 15. Epigenomics. 2025. PMID: 40231671 Review.
-
Sex differences in epigenetic ageing for older people living with HIV.EBioMedicine. 2025 Mar;113:105588. doi: 10.1016/j.ebiom.2025.105588. Epub 2025 Feb 8. EBioMedicine. 2025. PMID: 39923742 Free PMC article.
References
-
- Jones HT, Levett T, Barber TJ. Frailty in people living with HIV: an update. Curr Opin Infect Dis 2022; 35:21–30. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical